Drug interactions and the evolution of antibiotic resistance
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Large-scale, systems biology approaches now allow us to systematically map synergistic and antagonistic interactions between drugs. Consequently, drug antagonism is emerging as a powerful tool to study biological function and relatedness between cellular components as well as to uncover mechanisms of drug action. Furthermore, theoretical models and new experiments suggest that antagonistic interactions between antibiotics can counteract the evolution of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the interactions can be highly dosedependent”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
Global Mapping of the Yeast Genetic Interaction Network
Tong, A. H. Y., Lesage, G., Bader, G. D., Ding, H., Xu, H., Xin, X., Young, J., Berriz, G. F., Brost, R. L., Chang, M., et al. (2004) · Science · doi:10.1126/science.1091317 · Cited by 2,095
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Schuldiner, M., Collins, S. R., Thompson, N. J., Denic, V., Bhamidipati, A., Punna, T., Ihmels, J., Andrews, B., Boone, C., Greenblatt, J. F., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.031 · Cited by 870
Collins, S. R., Miller, K. M., Maas, N. L., Roguev, A., Fillingham, J., Chu, C. S., Schuldiner, M., Gebbia, M., Recht, J., Shales, M., et al. (2007) · Nature · doi:10.1038/nature05649 · Cited by 869
Modular epistasis in yeast metabolism
Segrè, D., DeLuna, A., Church, G. M., & Kishony, R. (2005) · Nature Genetics · doi:10.1038/ng1489 · Cited by 575
Self-citationEpistasis and the Evolutionary Process
Hurst, L. D. (2000) · Heredity · doi:10.1046/j.1365-2540.2000.0846b.x · Cited by 563
A DNA Integrity Network in the Yeast Saccharomyces cerevisiae
Pan, X., Ye, P., Yuan, D. S., Wang, X., Bader, J. S., & Boeke, J. D. (2006) · Cell · doi:10.1016/j.cell.2005.12.036 · Cited by 537 · cited 1×
“Systematic screens for synergy between double gene knockouts have been successfully used to understand biological systems in bacteria and yeas”
Cited by
Items 101–200 of 340
Hybrid antibiotics – clinical progress and novel designs
Parkes, A. L., & Yule, I. A. (2016) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2016.1187597 · Cited by 63
Tekin, E., Beppler, C., White, C., Mao, Z., Savage, V. M., & Yeh, P. J. (2016) · Journal of The Royal Society Interface · doi:10.1098/rsif.2016.0332 · Cited by 71
Self-citationNguyen, C. L., Markey, K. A., Miltiadous, O., Dai, A., Waters, N. R., Sadeghi, K. D., Fei, T., Shouval, R., Taylor, B. P., Liao, C., et al. (2023) · Cell · doi:10.1016/j.cell.2023.05.007 · Cited by 64
Вараксин, А. Н., Katsnelson, B. A., Panov, V. G., Privalova, L. I., Kireyeva, E. P., Valamina, I. E., & Beresneva, O. Y. (2013) · Food and Chemical Toxicology · doi:10.1016/j.fct.2013.11.024 · Cited by 59
Shavit, M., Pokrovskaya, V., Белахов, В. В., & Baasov, T. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.02.068 · Cited by 58
Synthetic RNA Silencing in Bacteria ? Antimicrobial Discovery and Resistance Breaking
Good, L., & Stach, J. E. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00185 · Cited by 56
“Reasons for this failure are multifaceted, but include the observation that, for single-target inhibitors, individual point mutations in the target gene may be sufficient to overcome inhibition (Yeh et al., 2009).”
BackgroundAlsherbiny, M. A., Bhuyan, D. J., Low, M., Chang, D., & Li, C. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810103 · Cited by 61
“Synergistic combinations offer the use of lower doses with reduced side effects and curtailed drug resistance [60,61].”
BackgroundEvolutionary ecology meets the antibiotic crisis
Roemhild, R., & Schulenburg, H. (2019) · Evolution Medicine and Public Health · doi:10.1093/emph/eoz008 · Cited by 58
“Such dynamics may be partially circumvented by special drug combinations that show suppressive interaction [11].”
BackgroundFactors favouring the evolution of multidrug resistance in bacteria
Jacopin, E., Lehtinen, S., Débarre, F., & Blanquart, F. (2020) · Journal of The Royal Society Interface · doi:10.1098/rsif.2020.0105 · Cited by 55
“In a similar way, the effect of treatment in reducing transmission 1 − ψi,m depends on the multiplicative effects of individual drugs present in the treatment and pairwise interactions for all pairs of drugs to which genotype i is sensitive [28,29].”
BackgroundPrediction of Antibiotic Interactions Using Descriptors Derived from Molecular Structure
Mason, D. J., Stott, I., Ashenden, S., Weinstein, Z. B., Karakoc, I., Meral, S., Kuru, N., Bender, A., & Cokol, M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00204 · Cited by 50
Kholodenko, B. N. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.014 · Cited by 49
“Interactions between two inhibitors or drugs also can be assessed by plotting inhibition effects across a two-dimensional range of drug doses, thereby creating a response surface (Keith et al., 2005; Yeh et al., 2009).”
BackgroundAlvarez‐Lorenzo, C., García‐González, C. A., Bucio, E., & Concheiro, Á. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1178719 · Cited by 51
Galeterone and VNPT 55 disrupt Mnk‐ eIF 4E to inhibit prostate cancer cell migration and invasion
Kwegyir‐Afful, A. K., Bruno, R. D., Purushottamachar, P., Murigi, F. N., & Njar, V. C. O. (2016) · FEBS Journal · doi:10.1111/febs.13895 · Cited by 51
Dillon, N. A., Holland, M. M., Tsunemoto, H., Hancock, B., Cornax, I., Pogliano, J., Sakoulas, G., & Nizet, V. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.041 · Cited by 52
Experimental evolution as an efficient tool to dissect adaptive paths to antibiotic resistance
Jansen, G., Barbosa, C., & Schulenburg, H. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.02.002 · Cited by 66
“, 2011; Mitchison, 2004), although its efficacy remains subject to considerable debate (Chow and Yu, 1999; Yeh et al., 2009; Tamma et al., 2011).”
BackgroundFrom Systems to Structure: Bridging Networks and Mechanism
Fraser, J. S., Gross, J. D., & Krogan, N. J. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.003 · Cited by 46
“Similar to genetic interactions, current efforts are underway to discover nonadditive effects in drug combinations (Yeh et al., 2009).”
Ankomah, P., Johnson, P. J., & Levin, B. R. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003300 · Cited by 54
“56MIC each of two additive drugs, 6CU = 1, would be equal to 16MIC of each of the antibiotics on their own [40].”
BackgroundSchlatter, D., & Kinkel, L. L. (2015) · BMC Evolutionary Biology · doi:10.1186/s12862-015-0470-6 · Cited by 46
“However, combinations of antibiotics, especially those with different modes of action, can substantially reduce the likelihood that any one competitor bears resistance to every antibiotic and may slow the evolution of novel resistances [31].”
Uncovering emergent interactions in three-way combinations of stressors
Beppler, C., Tekin, E., Mao, Z., White, C., McDiarmid, C., Vargas, E. A., Miller, J. H., Savage, V. M., & Yeh, P. J. (2016) · Journal of The Royal Society Interface · doi:10.1098/rsif.2016.0800 · Cited by 56
“Synergistic drug combinations are useful because they kill bacteria more effectively and are advantageous for individual patients, while antagonistic drug combinations are useful because they may be able to help slow the evolution of antibiotic resistance [4,11,12].”
BackgroundSelf-citationAlsherbiny, M. A., Bhuyan, D. J., Radwan, I., Chang, D., & Li, C. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22157840 · Cited by 46
“Combination therapies target different cellular pathways and block cancer evolution escape mechanisms and drug resistance [34].”
BackgroundA systematic analysis of signaling reactivation and drug resistance
Kholodenko, B. Ν., Rauch, N., Kölch, W., & Rukhlenko, O. S. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109157 · Cited by 44
“The efficiency of the ERK inhibition by a two-drug combination is comprehensively assessed by determining the ppERK response across a two-dimensional plane of drug doses (Keith et al., 2005; Yeh et al., 2009).”
BackgroundHorizontal gene transfer enables programmable gene stability in synthetic microbiota
Wang, T., Weiss, A., Aqeel, A., Wu, F., Lopatkin, A. J., David, L. A., & You, L. (2022) · Nature Chemical Biology · doi:10.1038/s41589-022-01114-3 · Cited by 41
Matthews, H., Deakin, J. A., May, R., Idris-Usman, M., & Nirmalan, N. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173303 · Cited by 45
“5B should be expected to achieve the same effect as drug 1A or 1B [16, 17].”
BackgroundModulation of antibiotic effects on microbial communities by resource competition
Newton, D., Ho, P.-Y., & Huang, K. C. (2023) · Nature Communications · doi:10.1038/s41467-023-37895-x · Cited by 45
“Moreover, concurrent application of multiple drugs can lead to synergistic or antagonistic effects 19 – 21 , whereby the degree of killing is greater or less, respectively, than the sum of the drugs individually.”
Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health
Perron, G. G., Inglis, R. F., Pennings, P. S., & Cobey, S. E. (2015) · Evolutionary Applications · doi:10.1111/eva.12254 · Cited by 44
“For example, combination therapy showed that some antibiotics have nonlinear inhibitory activities when used together (King et al. 1981; Yeh et al. 2009).”
BackgroundRamos, C. S., Ladeira, C., Zeferino, A. S., Dias, A., Faria, I., Cristovam, E., Gomes, M. C., & Ribeiro, E. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.11.009 · Cited by 44
Coetzee, J. F., Magstadt, D. R., Sidhu, P. K., Follett, L., Schuler, A. M., Krull, A. C., Cooper, V. L., Engelken, T. J., Kleinhenz, M. D., & O’Connor, A. M. (2019) · PLOS ONE · doi:10.1371/journal.pone.0219104 · Cited by 39
“The resulting drug antagonism is associated with poorer clinical outcomes [13,14].”
BackgroundBacterial responses to antibiotics and their combinations
Mitosch, K., & Bollenbach, T. (2014) · Environmental Microbiology Reports · doi:10.1111/1758-2229.12190 · Cited by 44
Chemical genetics in drug discovery
Cacace, E., Kritikos, G., & Typas, A. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.020 · Cited by 46
Prediction of drug cocktail effects when the number of measurements is limited
Zimmer, A., Tendler, A., Katzir, I., Mayo, A., & Alon, U. S. (2017) · PLoS Biology · doi:10.1371/journal.pbio.2002518 · Cited by 43
The State-of-the-Art Antibacterial Activities of Glycyrrhizin: A Comprehensive Review
Chen, R.-Y., Shi, J., Liu, Y., Yu, J., Li, C.-Y., Tao, F., Cao, J.-F., Yang, G., & Chen, J. (2024) · Microorganisms · doi:10.3390/microorganisms12061155 · Cited by 37
“Strongly effective drugs for the treatment of bacterial infections are needed due to several drawbacks of antibiotics active against multidrug-resistant bacteria [7].”
BackgroundSynergy Maps: exploring compound combinations using network-based visualization
Lewis, R., Guha, R., Korcsmáros, T., & Bender, A. (2015) · Journal of Cheminformatics · doi:10.1186/s13321-015-0090-6 · Cited by 39
“2) for all pairs combination data is also popular [3, 15, 16, 24, 25, 32]—nodes correspond to compounds, and edges to combinations, connecting their components.”
BackgroundHerbicide cycling has diverse effects on evolution of resistance in C hlamydomonas reinhardtii
Lagator, M., Vogwill, T., Colegrave, N., & Neve, P. (2012) · Evolutionary Applications · doi:10.1111/j.1752-4571.2012.00276.x · Cited by 37
“It could also be that the first mutations that get fixed in the population affect the fitness consequences of others, as reported for antibiotic resistance (Trindade et al. 2009; Yeh et al. 2009).”
BackgroundDiagonal Method to Measure Synergy Among Any Number of Drugs
Çakmak, M. Ç., Bakan, F., Çetiner, S., & Cokol, M. (2018) · Journal of Visualized Experiments · doi:10.3791/57713 · Cited by 38
Synthesis and antibacterial evaluation of novel pleuromutilin derivatives
Shang, R., Liu, Y., Xin, Z., Guo, W., Guo, Z., Hao, B., & Jianping, L. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.01.048 · Cited by 36
Searching for synergy in silico, in vitro and in vivo
Sucher, N. J. (2014) · Synergy · doi:10.1016/j.synres.2014.07.004 · Cited by 39
“by exposure of an organism to combination of drugs) is different from what is expected based on the individual ones [137,142,143].”
BackgroundImproved network performance via antagonism: From synthetic rescues to multi‐drug combinations
Motter, A. E. (2010) · BioEssays · doi:10.1002/bies.200900128 · Cited by 39
“The latter can have direct implications for medical research related to metabolic diseases and, combined with current studies on antagonistic drug interactions,((8)) lead to a new paradigm to address drug resistance in antibiotic and cancer research.”
BackgroundHe, H., Duo, H., Hao, Y., Zhang, X., Zhou, X., Zeng, Y., Li, Y., & Li, B. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.106671 · Cited by 36
Pajares‐Chamorro, N., Shook, J. C., Hammer, N. D., & Chatzistavrou, X. (2019) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.07.012 · Cited by 38
Naskar, A., Lee, S., Lee, Y., Kim, S., & Kim, K.-S. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12090841 · Cited by 39
“Notably, bacteria can reduce their interactions with antibiotics to result in drug resistance [22].”
BackgroundTHE EVOLUTIONARY EPIDEMIOLOGY OF MULTILOCUS DRUG RESISTANCE
Day, T., & Gandon, S. (2012) · Evolution · doi:10.1111/j.1558-5646.2011.01533.x · Cited by 38
“…when compensatory changes at secondary loci can ameliorate the costs of resistance at a focal locus, or when resistance to multiple drugs evolves (Maisnier-Patin and Andersson 2004; Weinreich et al. 2005; Poelwijk et al. 2007; Yeh et al. 2009; Andersson and Hughes 2010; MacLean et al. 2010).”
BackgroundInfluentialKim, S., Masum, F., Kim, J.-K., Chung, H. J., & Jeon, J. S. (2019) · Lab on a Chip · doi:10.1039/c8lc01406j · Cited by 37
Antimicrobial Activity of Protein Fraction from Naja ashei Venom against Staphylococcus epidermidis
Bocian, A., Ciszkowicz, E., Hus, K. K., Buczkowicz, J., Lecka-Szlachta, K., Pietrowska, M., Petrilla, V., Petrillová, M., Legáth, Ľ., & Legáth, J. (2020) · Molecules · doi:10.3390/molecules25020293 · Cited by 35
“The second possibility is to block the same metabolic pathway at different stages [49,50].”
BackgroundMeasuring higher-order drug interactions: A review of recent approaches
Tekin, E., Savage, V. M., & Yeh, P. J. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.015 · Cited by 38
Self-citationBessa, L. J., Palmeira, A., Gomes, A. S., Vasconcelos, V. M., Sousa, E., Pinto, M. M. M., & da Costa, P. M. (2015) · Microbial Drug Resistance · doi:10.1089/mdr.2014.0162 · Cited by 39
“52 To date, it is accepted that pharmacologically relevant ‘‘nonmonotonic’’ concentration/response relationships exist for both therapeutic and toxic actions of natural and synthetic compounds.”
Kim, S., Lee, S., Kim, J.-K., Chung, H. J., & Jeon, J. S. (2019) · Biomicrofluidics · doi:10.1063/1.5066558 · Cited by 39
Role of pleiotropy during adaptation of TEM ‐1 β‐lactamase to two novel antibiotics
Schenk, M., Witte, S., Salverda, M. L. M., Koopmanschap, B., Krug, J., & de Visser, J. A. G. M. (2014) · Evolutionary Applications · doi:10.1111/eva.12200 · Cited by 33
“Whether for designing cycling drug therapies or for designing strategies involving the simultaneous application of drug combinations (Yeh et al. 2009; Pena-Miller et al. 2013; Jansen et al. 2014), understanding the pleiotropic and epistatic properties of resistance mutations will be imperative…”
BackgroundInfluentialMutalik, V. K., & Arkin, A. P. (2022) · iScience · doi:10.1016/j.isci.2022.104121 · Cited by 32
“bacterial viruses), obligate parasites that infect and kill specific bacterial strains (Clatworthy et al., 2007; Yeh et al., 2009; Villa and Crespo, 2010; Kim et al., 2014; Baym et al., 2016; Czaplewski et al., 2016; Dickey et al., 2017; Mariathasan and Tan, 2017; Baker et al., 2018; Douafer et al., 2019; Heselpoth et…”
BackgroundTarget-Independent Prediction of Drug Synergies Using Only Drug Lipophilicity
Yılancıoğlu, K., Weinstein, Z., Meydan, C., Akhmetov, A., Toprak, I., Durmaz, A., Iossifov, I. H., Kazan, H., Roth, F. P., & Cokol, M. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500276x · Cited by 34
Antibiotic Resistance: Challenges and Strategies in Combating Infections
Chavada, J., Muneshwar, K. N., Ghulaxe, Y., Wani, M., Sarda, P. P., & Huse, S. (2023) · Cureus · doi:10.7759/cureus.46013 · Cited by 45
“Undoubtedly, scientific study has been done on the synergistic, additive, neutralizing, and antagonistic effects of antibiotics, but little is known about how antibiotics interact with the innate immune system [17,18].”
Soares, J. M., Corrêa, T. Q., Patiño, C. P. B., Gonçalves, I. S., dos Santos, G. G., Guimarães, G. G., de Lima, R. V., Lima, T. H. N., Corrêa, B. C., Cappellini, T. C. D. S., et al. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00369 · Cited by 38
“130,131 Alternatively, the Bliss independence model defines synergy based on the probability that at least one treatment contributes to an enhanced response.”
Nucleic acid combinations: A new frontier for cancer treatment
Remant Bahadur, K. C., Thapa, B., Valencia‐Serna, J., Aliabadi, H. M., & Uludağ, H. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.04.029 · Cited by 32
Abed, M. N., Abdullah, M. I., & Richardson, A. (2016) · Journal of Ovarian Research · doi:10.1186/s13048-016-0234-y · Cited by 30
“Bliss independence criterion [24, 25] was used to calculate the expected effect of drug combinations.”
MethodHow to kill Pseudomonas —emerging therapies for a challenging pathogen
Yaeger, L. N., Coles, V. E., Chan, D. C. K., & Burrows, L. L. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14596 · Cited by 36
Distributed Classifier Based on Genetically Engineered Bacterial Cell Cultures
Didovyk, A., Игоревич, К. О., Ivanchenko, M., Hasty, J., Huerta, R., & Tsimring, L. S. (2014) · ACS Synthetic Biology · doi:10.1021/sb500235p · Cited by 31
Minigalieva, I. A., Katsnelson, B. A., Panov, V. G., Вараксин, А. Н., Gurvich, V. B., Privalova, L. I., Sutunkova, M. P., & Klinova, S. V. (2017) · Toxicology Reports · doi:10.1016/j.toxrep.2017.04.002 · Cited by 29
“combined toxicity based on different paradigms depends essentially on the shape of the dose–effect curve for an isolated effect of each substance and on which segment of this curve the added effect of the second substance is considered [21,9,28].”
BackgroundWhen more is less: Emergent suppressive interactions in three-drug combinations
Beppler, C., Tekin, E., White, C., Mao, Z., Miller, J. H., Damoiseaux, R. D., Savage, V. M., & Yeh, P. J. (2017) · BMC Microbiology · doi:10.1186/s12866-017-1017-3 · Cited by 36
“In sum, there is intriguing and compelling evidence (although all in vitro and in silico) that suppressive combinations might be useful to combat resistance [8], but their rare occurrence makes their identification and use more daunting.”
BackgroundSelf-citationDetermination of antibiotic EC50 using a zero‐flow microfluidic chip based growth phenotype assay
Dai, J. H., Suh, S., Hamon, M., & Hong, J. W. (2015) · Biotechnology Journal · doi:10.1002/biot.201500037 · Cited by 28
Large-Scale Identification and Analysis of Suppressive Drug Interactions
Cokol, M., Weinstein, Z., Yılancıoğlu, K., Tasan, M., Doak, A. K., Cansever, D., Mutlu, B., Li, S., Rodriguez‐Esteban, R., Akhmedov, M., et al. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.02.012 · Cited by 30
“This phenomenon has been hypothesized, but not previously observed (Yeh et al., 2009).”
BackgroundInfluentialBuckley, P. T., Chan, R., Fernandez, J., Luo, J., Lacey, K. A., Dumont, A., O’Malley, A., Brezski, R. J., Zheng, S., Malia, T., et al. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.04.004 · Cited by 28
Pokrovskaya, V., Nudelman, I., Kandasamy, J., & Baasov, T. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(10)78021-6 · Cited by 33
“Indeed, recent studies on various physical combinations of antibiotics of different classes have demonstrated that, while synergistic combinations of antibiotics resulted in an increase in the selection of drug-resistant mutants, suppressive combinations greatly slowed the rate of accumulation of drug-resistant mutant…”
BackgroundAllen, R. C., & Brown, S. P. (2019) · mBio · doi:10.1128/mbio.01831-19 · Cited by 28
Mathematical models to study the biology of pathogens and the infectious diseases they cause
Xavier, J. B., Monk, J. M., Poudel, S., Norsigian, C. J., Sastry, A. V., Liao, C., Bento, J., Suchard, M. A., Arrieta‐Ortiz, M. L., Peterson, E. J. R., et al. (2022) · iScience · doi:10.1016/j.isci.2022.104079 · Cited by 30
“For example, computer models allow in silico systematic analysis of synergistic and antagonistic interactions between drugs (Yeh et al., 2009).”
BackgroundToxicodynamic and Toxicokinetic Descriptors of Combined Chromium (VI) and Nickel Toxicity
Minigalieva, I. A., Katsnelson, B. A., Privalova, L. I., Gurvich, V. B., Panov, V. G., Вараксин, А. Н., Makeyev, O. H., Sutunkova, M. P., Loginova, N. V., Kireyeva, E. P., et al. (2014) · International Journal of Toxicology · doi:10.1177/1091581814555915 · Cited by 25
Modification ofEscherichia coli–bacteriophage interactions by surfactants and antibioticsin vitro
Scanlan, P. D., Bischofberger, A. M., & Hall, A. R. (2016) · FEMS Microbiology Ecology · doi:10.1093/femsec/fiw211 · Cited by 27
“This is mathematically identical to a common approach for inferring epistatic interactions among genes or mutations (e.g. Phillips 2008; Trindade et al. 2009; Hall and MacLean 2011), and has also been used to identify interactions among pairs of antibiotics (Yeh et al. 2009).”
The optimal deployment of synergistic antibiotics: a control-theoretic approach
Peña‐Miller, R., Laehnemann, D., Schulenburg, H., Ackermann, M., & Beardmore, R. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2012.0279 · Cited by 26
“It has even been suggested, for example, that synergistic drug combinations, the ones usually preferred in clinical settings, may serve to promote the evolution of drug resistance [9, 4, 25].”
BackgroundmiR-195 potentiates the efficacy of microtubule-targeting agents in non-small cell lung cancer
Yu, X., Zhang, Y., Ma, X., & Pertsemlidis, A. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.04.007 · Cited by 23
Additivity and synergy between an antimicrobial peptide and inhibitory ions
Walkenhorst, W. F., Sundrud, J. N., & Laviolette, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.05.005 · Cited by 24
“Measuring and characterizing additivity and synergy have a long and intricate history [51–54,58,65–67].”
BackgroundSequential antibiotic therapy in the laboratory and in the patient
Nyhoegen, C., & Uecker, H. (2023) · Journal of The Royal Society Interface · doi:10.1098/rsif.2022.0793 · Cited by 24
Combination effect of therapies targeting the PI3K- and AR-signaling pathways in prostate cancer
Yadav, S. S., Li, J., Stockert, J. A., O’Connor, J., Herzog, B. J., Elaiho, C. R., Galsky, M. D., Tewari, A. K., & Yadav, K. K. (2016) · Oncotarget · doi:10.18632/oncotarget.12771 · Cited by 25
“Some drug combinations can be antagonistic and would require more of each drug to achieve similar outcomes [28].”
BackgroundYou Cannot Have Your Synergy and Efficacy Too
Sen, P., Saha, A., & Dixit, N. M. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.08.008 · Cited by 21
“Finally, we recognize that synergistic drug combinations may accelerate the evolution of multidrug resistance, and conditions that preclude such evolution are screened for in optimizing treatments [18].”
BackgroundFine-tuning of ecaA and pepc gene expression increases succinic acid production in Escherichia coli
Wang, J., Qin, D., Zhang, B., Li, Q., Li, S., Zhou, X., Dong, L., & Wang, D. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6734-7 · Cited by 21
“, the synthesis of antibiotic, antibody, and new treatments (Yeh et al. 2009; Langer and Tirrell 2004; Leitao and Engutia 2014), biological energy source, e.”
BackgroundEvolution of resistance to single and combined floral phytochemicals by a bumble bee parasite
Palmer‐Young, E. C., Sadd, B. M., & Adler, L. S. (2016) · Journal of Evolutionary Biology · doi:10.1111/jeb.13002 · Cited by 24
Chueca, B., Renzoni, A., Berdejo, D., Pagán, R., Kelley, W. L., & García‐Gonzalo, D. (2018) · Applied and Environmental Microbiology · doi:10.1128/aem.02538-17 · Cited by 20
Resource Competition May Lead to Effective Treatment of Antibiotic Resistant Infections
Gomes, A. L. C., Galagan, J. E., & Segrè, D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080775 · Cited by 22
“In the battle against antibiotic resistance, the use of mathematical models is important for transforming the cumulative understanding of the mechanisms for acquisition and loss of resistance [27,75,76] into potential strategies to treat infection caused by resistant pathogens.”
BackgroundExploring the Molecular Basis of Antifungal Synergies Using Genome-Wide Approaches
Agarwal, A. K., Tripathi, S., Xu, T., Jacob, M. R., Li, X., & Clark, A. M. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00115 · Cited by 21
“be synergistic if they inhibit two proteins in parallel pathways (Yeh et al., 2009).”
Mahmud, H. A., & Wakeman, C. A. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1478789 · Cited by 23
Trustworthy Deep Neural Network for Inferring Anticancer Synergistic Combinations
Alsherbiny, M. A., Radwan, I., Moustafa, N., Bhuyan, D. J., El-Waisi, M., Chang, D., & Li, C. G. (2021) · IEEE Journal of Biomedical and Health Informatics · doi:10.1109/jbhi.2021.3126339 · Cited by 19
“It was reported that combination therapy could target multiple cellular mechanisms involved in drug resistance in different cancers [10].”
BackgroundExploring antibiotic resistance with chemical tools
Velema, W. A. (2023) · Chemical Communications · doi:10.1039/d3cc00759f · Cited by 19
The optimization of microbial functions through rational environmental manipulations
Sánchez, Á., Arrabal, A., Román, M. S., & Díaz‐Colunga, J. (2024) · Molecular Microbiology · doi:10.1111/mmi.15236 · Cited by 21
“It has been shown that antibiotics targeting different cellular processes often act synergistically (Cacace et al., 2023; Yeh et al., 2006), whereby the detrimental effect of an antibiotic is higher than expected when a second antibiotic is present too (Yeh et al., 2009).”
Nainu, F., Asri, R. M., Arsyad, A., Manggau, M. A., & Amir, M. N. (2018) · Pharmacognosy Journal · doi:10.5530/pj.2018.5.169 · Cited by 19
Hemoglobin and hematocrit: an analysis of clinical accuracy. Case study of the anemic patient.
Keen, M. L. (1998) · PubMed · Cited by 23
Stochastic competitive release and adaptive chemotherapy
Park, J., & Newton, P. K. (2023) · Physical review. E · doi:10.1103/physreve.108.034407 · Cited by 18
Nguyen, C., Zhou, A. L., Khan, A., Miller, J. H., & Yeh, P. J. (2016) · The Journal of Antibiotics · doi:10.1038/ja.2016.26 · Cited by 19
Self-citationTome, M., Zupan, J., Tomičić, Z., Matos, T., & Raspor, P. (2018) · PeerJ · doi:10.7717/peerj.4999 · Cited by 21
“Bliss independence The expected effect of drug combinations was also calculated by a model based on the Bliss independence (BI) criterion, where we assume that the relative effect of a drug at a particular concentration is independent of the presence of the other drug (Bliss, 1939; Goldoni & Johansson, 2007;Yeh et al.…”
BackgroundMethodShang, R., Wang, S., Xu, X., Yi, Y., Guo, W., YuLiu, & Liang, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0082595 · Cited by 18
“In the last three decades the abuse of antibiotics has made more pathogenic bacteria resistance to drugs, which leads to many available drugs reducing or losing curative effect [1].”
BackgroundLee, Y. H., & Helmann, J. D. (2014) · Journal of Bacteriology · doi:10.1128/jb.02022-14 · Cited by 24
“Combinations of antibiotics have emerged as a promising strategy to enhance antibiotic effectiveness (4, 5), and they are commonly classified as additive (no interaction), synergistic (greater than the additive effect), or antagonistic (less than the additive effect) (6, 7).”
BackgroundACDB: An Antibiotic Combination DataBase
Lv, J. Z., Liu, G., Dong, W., Ju, Y., & Sun, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.869983 · Cited by 17
“For synergistic antibiotic combinations, they are frequently used in clinics because they can provide improved ef fi cacy at lower dosages (Yeh et al., 2009).”
MethodWang, Q., Shen, B., Qin, X., Liu, S., & Feng, J. (2019) · Translational Cancer Research · doi:10.21037/tcr.2018.12.34 · Cited by 17
“com inhibition model suggested that two drugs will be synergistic if they inhibit two proteins on parallel pathways essential for an observed phenotype (29).”
BackgroundSaini, M., Gaurav, A., Kothari, A., Omar, B. J., Gupta, V., Bhattacharjee, A., & Pathania, R. (2023) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.2c00622 · Cited by 17
A model of optimal dosing of antibiotic treatment in biofilm
Imran, M., & Smith, H. L. (2014) · Mathematical Biosciences & Engineering · doi:10.3934/mbe.2014.11.547 · Cited by 19
Integrating multi-source drug information to cluster drug-drug interaction network
Lv, J. Z., Liu, G., Ju, Y., Sun, B., Huang, H., & Sun, Y. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107088 · Cited by 16
Li, Y., Wang, J., Zhang, G., Zhu, M., You, X., Hu, X., Zhang, F., & Wang, Y. (2018) · Chemistry & Biodiversity · doi:10.1002/cbdv.201800560 · Cited by 16
Peña‐Miller, R., Laehnemann, D., Schulenburg, H., Ackermann, M., & Beardmore, R. (2011) · Bulletin of Mathematical Biology · doi:10.1007/s11538-011-9698-5 · Cited by 19
“However, one might equally argue that higher doses of antibiotic impose stronger selective pressures in favour of drug-resistant bacteria (Yeh et al. 2009).”
Discovery of Novel Coumarin Pleuromutilin Derivatives as Potent Anti-MRSA Agents
Liu, K., Xia, J., Li, Y., Li, B., Wang, M.-Q., Zhou, Q., Ma, M., He, Q., Yang, W., Liu, D., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01678 · Cited by 15
Silver, L. L. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2017_24 · Cited by 19
“In fact, that group demonstrated that antagonistic (as opposed to synergistic) interactions can even suppress resistance selection [127, 128].”
BackgroundMogre, A., Veetil, R. T., & Seshasayee, A. S. N. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.300284 · Cited by 17
“Such therapies could complement other strategies e.g. , using a combination of antibiotics (Chait et al. 2007; Michel et al. 2008; Yeh et al. 2009; Torella et al. 2010; Baym et al. 2016).”
Synergistic Drug Combinations Promote the Development of Resistance in Acute Myeloid Leukemia
Mason‐Osann, E., Pomeroy, A. E., Palmer, A. C., & Mettetal, J. T. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-23-0067 · Cited by 16
“In this study, we investigated whether synergistic drug combinations promote resistance in cancer cells, as previously shown in bacteria and predicted by computational models (7, 11, 12).”
BackgroundDua, R., Ma, Y., & Newton, P. K. (2021) · Cancers · doi:10.3390/cancers13122880 · Cited by 14
Diamant, E. S., Boyd, S. M., Lozano-Huntelman, N. A., Enriquez, V., Kim, A. R., Savage, V. M., & Yeh, P. J. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.161163 · Cited by 17
Self-citation
Metadata
- Authors
- Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Kishony, Roy
- Venue
- Nature Reviews Microbiology
- Published
- 2009-06
- Volume
- 7
- Issue
- 6
- Pages
- 460-466
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC2855488
- OpenAlex
- W2115076532
- Cited by
- 350
- References
- 68
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 23 · 2023: 29 · 2022: 22 · 2021: 27 · 2020: 14 · 2019: 23 · 2018: 22 · 2017: 29 · 2016: 23 · 2015: 16 · 2014: 31 · 2013: 20 · 2012: 13
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- National Institutes of Health
- National Defense Science and Engineering Graduate
- National Institute of General Medical Sciences (R01GM081617)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- drug interactions, antibiotic resistance, drug antagonism, drug synergy, systems biology, mechanisms of drug action, resistance evolution
- MeSH terms
- Drug Antagonism, Drug Interactions, Drug Resistance, Microbial, Drug Synergism, Models, Theoretical, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.